199 related articles for article (PubMed ID: 25468896)
21. Macular Carotenoid Supplementation Improves Visual Performance, Sleep Quality, and Adverse Physical Symptoms in Those with High Screen Time Exposure.
Stringham JM; Stringham NT; O'Brien KJ
Foods; 2017 Jun; 6(7):. PubMed ID: 28661438
[TBL] [Abstract][Full Text] [Related]
22. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
23. Nutrient Supplementation for Age-related Macular Degeneration, Cataract, and Dry Eye.
Hobbs RP; Bernstein PS
J Ophthalmic Vis Res; 2014; 9(4):487-93. PubMed ID: 25709776
[TBL] [Abstract][Full Text] [Related]
24. Antioxidative capacity of a dietary supplement on retinal hemodynamic function in a human lipopolysaccharide (LPS) model.
Told R; Schmidl D; Palkovits S; Boltz A; Gouya G; Wolzt M; Witkowska KJ; Popa-Cherecheanu A; Werkmeister RM; Garhöfer G; Schmetterer L
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):403-11. PubMed ID: 25525163
[TBL] [Abstract][Full Text] [Related]
25. Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy.
Gong X; Rubin LP
Arch Biochem Biophys; 2015 Apr; 572():40-48. PubMed ID: 25701588
[TBL] [Abstract][Full Text] [Related]
26. Nutritional supplements in age-related macular degeneration.
Schmidl D; Garhöfer G; Schmetterer L
Acta Ophthalmol; 2015 Mar; 93(2):105-21. PubMed ID: 25586104
[TBL] [Abstract][Full Text] [Related]
27. The Association of Dietary Lutein plus Zeaxanthin and B Vitamins with Cataracts in the Age-Related Eye Disease Study: AREDS Report No. 37.
Glaser TS; Doss LE; Shih G; Nigam D; Sperduto RD; Ferris FL; Agrón E; Clemons TE; Chew EY;
Ophthalmology; 2015 Jul; 122(7):1471-9. PubMed ID: 25972257
[TBL] [Abstract][Full Text] [Related]
28. Effect of Omega-3 Fatty Acids, Lutein/Zeaxanthin, or Other Nutrient Supplementation on Cognitive Function: The AREDS2 Randomized Clinical Trial.
Chew EY; Clemons TE; Agrón E; Launer LJ; Grodstein F; Bernstein PS;
JAMA; 2015 Aug; 314(8):791-801. PubMed ID: 26305649
[TBL] [Abstract][Full Text] [Related]
29. Changes in Macular Pigment Optical Density and Serum Lutein Concentration in Japanese Subjects Taking Two Different Lutein Supplements.
Obana A; Tanito M; Gohto Y; Okazaki S; Gellermann W; Bernstein PS
PLoS One; 2015; 10(10):e0139257. PubMed ID: 26451726
[TBL] [Abstract][Full Text] [Related]
30. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration.
Akuffo KO; Nolan JM; Howard AN; Moran R; Stack J; Klein R; Klein BE; Meuer SM; Sabour-Pickett S; Thurnham DI; Beatty S
Eye (Lond); 2015 Jul; 29(7):902-12. PubMed ID: 25976647
[TBL] [Abstract][Full Text] [Related]
31. Association of macular pigment optical density with serum concentration of oxidized low-density lipoprotein in healthy adults.
Nagai N; Izumi-Nagai K; Suzuki M; Shinoda H; Koto T; Uchida A; Mochimaru H; Tomita Y; Miyake S; Kobayashi S; Sasaki M; Tsubota K; Ozawa Y
Retina; 2015 Apr; 35(4):820-6. PubMed ID: 25473786
[TBL] [Abstract][Full Text] [Related]
32. The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.
Jia YP; Sun L; Yu HS; Liang LP; Li W; Ding H; Song XB; Zhang LJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28425969
[TBL] [Abstract][Full Text] [Related]
33. Macular pigment carotenoids in the retina and occipital cortex are related in humans.
Vishwanathan R; Schalch W; Johnson EJ
Nutr Neurosci; 2016; 19(3):95-101. PubMed ID: 25752849
[TBL] [Abstract][Full Text] [Related]
34. Effects of a Lutein and Zeaxanthin Intervention on Cognitive Function: A Randomized, Double-Masked, Placebo-Controlled Trial of Younger Healthy Adults.
Renzi-Hammond LM; Bovier ER; Fletcher LM; Miller LS; Mewborn CM; Lindbergh CA; Baxter JH; Hammond BR
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29135938
[No Abstract] [Full Text] [Related]
35. Macular carotenoid supplementation improves disability glare performance and dynamics of photostress recovery.
Stringham JM; O'Brien KJ; Stringham NT
Eye Vis (Lond); 2016; 3():30. PubMed ID: 27857944
[TBL] [Abstract][Full Text] [Related]
36. Contrast Sensitivity and Lateral Inhibition Are Enhanced With Macular Carotenoid Supplementation.
Stringham JM; O'Brien KJ; Stringham NT
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2291-2295. PubMed ID: 28431432
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of dietary patterns among Norwegian postmenopausal women using plasma carotenoids as biomarkers.
Markussen MS; Veierød MB; Sakhi AK; Ellingjord-Dale M; Blomhoff R; Ursin G; Andersen LF
Br J Nutr; 2015 Feb; 113(4):672-82. PubMed ID: 25622727
[TBL] [Abstract][Full Text] [Related]
38. Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.
Bernstein PS; Li B; Vachali PP; Gorusupudi A; Shyam R; Henriksen BS; Nolan JM
Prog Retin Eye Res; 2016 Jan; 50():34-66. PubMed ID: 26541886
[TBL] [Abstract][Full Text] [Related]
39. Lutein and Factor D: two intriguing players in the field of age-related macular degeneration.
Tian Y; Kijlstra A; Webers CAB; Berendschot TTJM
Arch Biochem Biophys; 2015 Apr; 572():49-53. PubMed ID: 25637656
[TBL] [Abstract][Full Text] [Related]
40. Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids.
Wolf-Schnurrbusch UE; Zinkernagel MS; Munk MR; Ebneter A; Wolf S
Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8069-74. PubMed ID: 26720458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
